Companion Nanodiagnostics for Quantifying EPR and Stratifying Patients to Targeted Nanotherapies

Project Information

CONQUEST

Grant agreement ID: 680882

DOI

10.3030/680882

Project closed

EC signature date 25 November 2015

Start date 1 January 2016

End date 30 June 2017

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 145 312,00

EU contribution

€ 145 312,00

Coordinated by

UNIVERSITAETSKLINIKUM AACHEN
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (7)

Enhancing Tumor Penetration of Nanomedicines

Author(s): Qingxue Sun, Tarun Ojha, Fabian Kiessling, Twan Lammers, Yang Shi
Published in: Biomacromolecules, Issue 18/5, 2017, Page(s) 1449-1459, ISSN 1525-7797
Publisher: American Chemical Society
DOI: 10.1021/acs.biomac.7b00068

Cancer nanomedicine: is targeting our target?

Author(s): Twan Lammers, Fabian Kiessling, Marianne Ashford, Wim Hennink, Daan Crommelin, Gert Strom
Published in: Nature Reviews Materials, Issue 1/9, 2016, Page(s) 16069, ISSN 2058-8437
Publisher: Nature Publishing Group
DOI: 10.1038/natrevmats.2016.69

Physico-Chemical Strategies to Enhance Stability and Drug Retention of Polymeric Micelles for Tumor-Targeted Drug Delivery

Author(s): Yang Shi, Twan Lammers, Gert Storm, Wim E. Hennink
Published in: Macromolecular Bioscience, Issue 17/1, 2017, Page(s) 1600160, ISSN 1616-5187
Publisher: John Wiley & Sons Ltd.
DOI: 10.1002/mabi.201600160

Challenges and strategies in anti-cancer nanomedicine development: An industry perspective

Author(s): Jennifer I. Hare, Twan Lammers, Marianne B. Ashford, Sanyogitta Puri, Gert Storm, Simon T. Barry
Published in: Advanced Drug Delivery Reviews, Issue 108, 2017, Page(s) 25-38, ISSN 0169-409X
Publisher: Elsevier BV
DOI: 10.1016/j.addr.2016.04.025

Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors

Author(s): Tarun Ojha, Vertika Pathak, Yang Shi, Wim E. Hennink, Chrit T.W. Moonen, Gert Storm, Fabian Kiessling, Twan Lammers
Published in: Advanced Drug Delivery Reviews, 2017, ISSN 0169-409X
Publisher: Elsevier BV
DOI: 10.1016/j.addr.2017.07.007

Tumor-targeted nanomedicines for cancer theranostics

Author(s): Alexandra G. Arranja, Vertika Pathak, Twan Lammers, Yang Shi
Published in: Pharmacological Research, Issue 115, 2017, Page(s) 87-95, ISSN 1043-6618
Publisher: Academic Press
DOI: 10.1016/j.phrs.2016.11.014

Targeting iron metabolism in drug discovery and delivery

Author(s): Bart J. Crielaard, Twan Lammers, Stefano Rivella
Published in: Nature Reviews Drug Discovery, Issue 16/6, 2017, Page(s) 400-423, ISSN 1474-1776
Publisher: Nature Publishing Group
DOI: 10.1038/nrd.2016.248

Intellectual Property Rights

Patent (1)

Amphiphilic block copolymers for delivery of active agents

Application/Publication number: WO 2016024861 A1
Date: 2015-08-11
Applicant(s): UNIVERSITAETSKLINIKUM AACHEN